These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 7792436)

  • 61. In vitro restructuring effect of human airway immunoglobulins A and lysozyme on airway secretions.
    Puchelle E; Jacqot J; Zahm JM
    Eur J Respir Dis Suppl; 1987; 153():117-22. PubMed ID: 3480810
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epithelial cell dysfunction in cystic fibrosis: implications for airways disease.
    Boat TF; Cheng PW
    Acta Paediatr Scand Suppl; 1989; 363():25-9; discussion 29-30. PubMed ID: 2701921
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exogenous surfactant therapy and mucus rheology in chronic obstructive airway diseases.
    Banerjee R; Puniyani RR
    J Biomater Appl; 2000 Jan; 14(3):243-72. PubMed ID: 10656543
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mucus-controlling agents: past and present.
    King M; Rubin BK
    Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Muco-ciliary clearance: A review of modelling techniques.
    M Vanaki S; Holmes D; Saha SC; Chen J; Brown RJ; Jayathilake PG
    J Biomech; 2020 Jan; 99():109578. PubMed ID: 31916998
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive pulmonary diseases.
    Girod S; Galabert C; Lecuire A; Zahm JM; Puchelle E
    Pediatr Pulmonol; 1992 May; 13(1):22-7. PubMed ID: 1589308
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regulation of salt and water transport across airway mucosa.
    Al-Bazzaz FJ
    Clin Chest Med; 1986 Jun; 7(2):259-72. PubMed ID: 2872993
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis.
    Bush A; Payne D; Pike S; Jenkins G; Henke MO; Rubin BK
    Chest; 2006 Jan; 129(1):118-23. PubMed ID: 16424421
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
    Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cystic Fibrosis Sputum Rheology Correlates With Both Acute and Longitudinal Changes in Lung Function.
    Ma JT; Tang C; Kang L; Voynow JA; Rubin BK
    Chest; 2018 Aug; 154(2):370-377. PubMed ID: 29559310
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Specialized proresolving mediator resolvin E1 corrects the altered cystic fibrosis nasal epithelium cilia beating dynamics.
    Briottet M; Sy K; London C; Aissat A; Shum M; Escabasse V; Louis B; Urbach V
    Proc Natl Acad Sci U S A; 2024 Jan; 121(5):e2313089121. PubMed ID: 38252817
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease.
    Matsui H; Grubb BR; Tarran R; Randell SH; Gatzy JT; Davis CW; Boucher RC
    Cell; 1998 Dec; 95(7):1005-15. PubMed ID: 9875854
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus.
    Fernandez-Petty CM; Hughes GW; Bowers HL; Watson JD; Rosen BH; Townsend SM; Santos C; Ridley CE; Chu KK; Birket SE; Li Y; Leung HM; Mazur M; Garcia BA; Evans TIA; Libby EF; Hathorne H; Hanes J; Tearney GJ; Clancy JP; Engelhardt JF; Swords WE; Thornton DJ; Wiesmann WP; Baker SM; Rowe SM
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996141
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A new paradigm in respiratory hygiene: modulating respiratory secretions to contain cough bioaerosol without affecting mucus clearance.
    Zayas G; Valle JC; Alonso M; Alfaro H; Vega D; Bonilla G; Reyes M; King M
    BMC Pulm Med; 2007 Aug; 7():11. PubMed ID: 17697323
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acid exposure disrupts mucus secretion and impairs mucociliary transport in neonatal piglet airways.
    Liao YSJ; Kuan SP; Guevara MV; Collins EN; Atanasova KR; Dadural JS; Vogt K; Schurmann V; Bravo L; Eken E; Sponchiado M; Reznikov LR
    Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L873-L887. PubMed ID: 32160007
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.
    Middleton PG; Geddes DM; Alton EW
    Thorax; 1993 Aug; 48(8):812-6. PubMed ID: 8211871
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rheological profile of nesosteine: a new mucoactive agent.
    Braga PC; Beghi G; Castelli C; Grasselli G; Ornaghi A; Rampoldi C; Zheng Y; Allegra L
    Int J Clin Pharmacol Res; 1989; 9(1):77-83. PubMed ID: 2707929
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glutathione and bicarbonate nanoparticles improve mucociliary transport in cystic fibrosis epithelia.
    Cho DY; Rivers NJ; Lim DJ; Zhang S; Skinner D; Yang L; Menon AJ; Kelly OJ; Jones MP; Bicknell BT; Grayson JW; Harris E; Rowe SM; Woodworth BA
    Int Forum Allergy Rhinol; 2024 Jun; 14(6):1026-1035. PubMed ID: 37975554
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis.
    Knowles MR; Olivier K; Noone P; Boucher RC
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S65-9. PubMed ID: 7533608
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Other mucoactive agents for cystic fibrosis.
    Bye PT; Elkins MR
    Paediatr Respir Rev; 2007 Mar; 8(1):30-9. PubMed ID: 17419976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.